Each filer's latest filing for 413197104 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| BlackRock, Inc. 13G/A | 12.6% |
10/27/2026
Event 9/30/2026
|
||
| Marshman Fund Trust II 13G/A | 10.6% |
2/10/2025
Event 12/31/2024
|
||
|
FMR LLC
13G/A
|
5.4% |
2/5/2026
Event 12/31/2025
|
||
| FMR LLC | 5.4% | |||
| Abigail P. Johnson | 5.4% | |||
| Vanguard Portfolio Management LLC 13G | 5.1% |
7/31/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Valor IV Pharma Holdings, LLC
13G/A
|
3.2% |
11/14/2025
Event 9/30/2025
|
||
| Valor IV Pharma Holdings, LLC | 0% | |||
| Valor Equity Partners IV L.P. | 1.3% | |||
| Valor Equity Partners IV-A L.P. | 0% | |||
| Valor Equity Partners IV-B L.P. | 0.7% | |||
| Valor Equity Associates IV L.P. | 2.2% | |||
| Valor Equity Capital IV LLC | 2.2% | |||
| Valor Management L.P. | 2.2% | |||
| Antonio J. Gracias | 3.2% | |||
| Juan A. Sabater | 2.4% | |||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 228 | 28.8 M | $1.12B |
| 2026 Q2 | 329 | 54.2 M | $1.96B |
| 2026 Q1 | 313 | 56.0 M | $1.56B |
| 2025 Q4 | 326 | 50.1 M | $1.87B |
| 2025 Q3 | 302 | 47.4 M | $1.31B |
| 2025 Q2 | 283 | 51.3 M | $1.62B |
| 2025 Q1 | 274 | 50.3 M | $1.67B |
| 2024 Q4 | 248 | 52.8 M | $1.82B |
| 2024 Q3 | 236 | 50.2 M | $2.01B |
| 2024 Q2 | 221 | 50.2 M | $1.51B |
| 2024 Q1 | 211 | 49.0 M | $1.64B |
| 2023 Q4 | 222 | 47.9 M | $1.54B |
| 2023 Q3 | 207 | 49.5 M | $1.62B |
| 2023 Q2 | 212 | 52.0 M | $1.83B |
| 2023 Q1 | 219 | 51.5 M | $1.68B |
| 2022 Q4 | 244 | 51.4 M | $2.81B |
| 2022 Q3 | 206 | 50.7 M | $2.24B |
| 2022 Q2 | 186 | 48.1 M | $2.39B |
| 2022 Q1 | 184 | 46.1 M | $2.26B |
| 2021 Q4 | 149 | 44.6 M | $1.90B |
| 2021 Q3 | 103 | 30.9 M | $1.19B |
| 2021 Q2 | 85 | 28.0 M | $790M |
| 2021 Q1 | 58 | 27.5 M | $908M |
| 2020 Q4 | 60 | 28.0 M | $998M |
| 2020 Q3 | 45 | 28.5 M | $941M |